Hepatocellular carcinoma in cirrhotic liver with graft-versus-host disease

Ann Hematol. 2012 Sep;91(9):1501-2. doi: 10.1007/s00277-012-1416-3.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Carcinoma, Hepatocellular / etiology*
  • Carcinoma, Hepatocellular / surgery
  • Carcinoma, Hepatocellular / therapy
  • Catheter Ablation
  • Chronic Disease
  • Combined Modality Therapy
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use
  • Embolization, Therapeutic
  • Esophageal and Gastric Varices / diagnosis
  • Esophageal and Gastric Varices / etiology
  • Female
  • Graft vs Host Disease / complications*
  • Graft vs Host Disease / drug therapy
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Leukemia, Myeloid, Chronic-Phase / surgery*
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / diagnosis
  • Liver Neoplasms / etiology*
  • Liver Neoplasms / surgery
  • Liver Neoplasms / therapy
  • Middle Aged
  • Postoperative Complications / etiology*
  • Prednisolone / adverse effects
  • Prednisolone / therapeutic use

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Prednisolone